🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

109+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 109 recruiting trials for “amyotrophic-lateral-sclerosis-als

NARecruitingNCT07127172

GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

🏥 Neuralink Corp📍 2 sites📅 Started Jul 2025View details ↗
NARecruitingNCT07292545

Video-Based Proprioceptive Exercise Program in ALS

🏥 Tarsus University📍 1 site📅 Started Jul 2025View details ↗
RecruitingNCT07491484

Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth

🏥 TidalHealth, Inc.📍 1 site📅 Started Jul 2025View details ↗
NARecruitingNCT07006571

At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis

👨‍⚕️ Alberto Benussi, MD, University of Trieste📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06992596

UAE-PRIME: A Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

👨‍⚕️ Florian Roser, MD, Cleveland Clinic Abu Dhabi📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06527222

A Study of Ranolazine in ALS

👨‍⚕️ Jeffrey Statland, MD, University of Kansas Medical Center📍 7 sites📅 Started Apr 2025View details ↗
RecruitingNCT06878235

Validation of the French Version of the Primary Lateral Sclerosis Functioning Rating Scale (PLSFRS)

👨‍⚕️ Philippe CORCIA, PR, University Hospital, Tours📍 7 sites📅 Started Apr 2025View details ↗
NARecruitingNCT06877143

Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis

👨‍⚕️ Christine Herrmann, Dr., University of Ulm📍 1 site📅 Started Mar 2025View details ↗
Enrolling by InvitationNCT06875739

An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy

🏥 Fondazione Don Carlo Gnocchi Onlus📍 4 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06649955

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

🏥 PathMaker Neurosystems Inc.📍 1 site📅 Started Feb 2025View details ↗
EARLY_Phase 1RecruitingNCT06891716

[18F]ACI-19626 PET in TDP-43 Proteinopathies

👨‍⚕️ Elsmarieke van de Giessen, MD, Amsterdam UMC📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06810219

Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS

👨‍⚕️ Chris Principal Investigator, Cognixion📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06551649

Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation

👨‍⚕️ Ornella Parolini, Fondazione Policlinico Universitario A. Gemelli, IRCCS📍 2 sites📅 Started Jan 2025View details ↗
EARLY_Phase 1RecruitingNCT06849609

A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS

🏥 Hong Chen📍 1 site📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT04220190

RAPA-501 Therapy for ALS

👨‍⚕️ Daniel Fowler, M.D., Rapa Therapeutics LLC📍 1 site📅 Started Jan 2025View details ↗
Phase 1RecruitingNCT06556394

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation

🏥 Ractigen Therapeutics.📍 3 sites📅 Started Dec 2024View details ↗
Phase 1RecruitingNCT06598202

Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

👨‍⚕️ Junwei Hao, MD; PhD, Xuanwu Hospital, Beijing📍 1 site📅 Started Dec 2024View details ↗
RecruitingNCT06820008

Measurement and Impact of Physical Impairment in Amyotrophic Lateral Sclerosis: Use of Digital Technologies - A Precision ALS Project

👨‍⚕️ Dara Meldrum, PhD, University of Dublin, Trinity College📍 1 site📅 Started Nov 2024View details ↗
Phase 1RecruitingNCT06671236

Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases

🏥 Novabio Therapeutics📍 1 site📅 Started Nov 2024View details ↗
Phase 2RecruitingNCT06249867

A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

👨‍⚕️ Oliver Blanchard, MD, McGill University - Montreal Neurological Institute📍 2 sites📅 Started Nov 2024View details ↗
← PreviousPage 2 of 6Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →